The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
PBMs run prescription drug coverage for insurers ... insulin has emerged as a big campaign topic during this year’s ...
In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit ...
And when getting a prescription filled requires waiting hours — or even days. “Pharmacists used to be busy if they filled 200 ...
Rand told lawmakers that for about the past year, health insurance plans and pharmacy benefit managers have been reimbursing ...
A recent report from U.S. Pharmacist reveals that almost 46% of Americans are prescribed at least one medication each month.